Related Experiment Video
Updated: Aug 8, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Changes in upper airways microbiota in ventilator-associated pneumonia.
Laura Alagna1, Leonardo Mancabelli2,3, Federico Magni4
1Infectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. laura.alagna@policlinico.mi.it.
Mechanically ventilated patients who developed ventilator-associated pneumonia (VAP) had lower upper airway microbial diversity at intubation compared to those who did not. This finding suggests a potential link between initial airway microbiota and VAP risk.
Area of Science:
- Microbiology
- Critical Care Medicine
- Pulmonary Medicine
Background:
- The relationship between upper airway microbiota and ventilator-associated pneumonia (VAP) in mechanically ventilated (MV) patients remains unclear.
- Understanding this association is crucial for developing preventative strategies against VAP.
Purpose of the Study:
- To investigate the characteristics of upper airway microbiota in MV patients who developed VAP versus those who did not.
- To explore the temporal variations in microbiota composition over the course of mechanical ventilation.
Main Methods:
- Prospective observational study analyzing endotracheal aspirates from MV patients.
- 16S-rRNA gene profiling was used to assess microbiota composition at intubation (T0) and 72 hours (T3).
- Comparison between VAP cases and matched non-VAP (NO-VAP) controls.
Main Results:
- VAP patients exhibited significantly lower microbial diversity in upper airways at intubation compared to NO-VAP controls (p < 0.012).
- Both groups showed a decrease in microbial diversity from T0 to T3.
- Specific bacterial genera were lost or became predominant in VAP patients by T3, but the causal relationship remains undetermined.
Conclusions:
- Reduced microbial diversity in the upper airways at the time of intubation may be associated with an increased risk of VAP in MV patients.
- Further research is needed to elucidate whether VAP causes dysbiosis or if pre-existing dysbiosis contributes to VAP development.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

